Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
RATIONALE: Pathological impulsivity is a prominent feature in several psychiatric disorders, but detailed understanding of the specific neuronal processes underlying impulsive behavior is as yet lacking. OBJECTIVES: As recent findings have suggested involvement of the brain cannabinoid system in impulsivity, the present study aimed at further elucidating the role of cannabinoid CB(1) receptor activation in distinct measures of impulsive behavior. MATERIALS AND METHODS: The effects of the selective cannabinoid CB(1) receptor antagonist, rimonabant (SR141716A) and agonist WIN55,212-2 were tested in various measures of impulsive behavior, namely, inhibitory control in a five-choice serial reaction time task (5-CSRTT), impulsive choice in a delayed reward paradigm, and response inhibition in a stop-signal paradigm. RESULTS: In the 5-CSRTT, SR141716A dose-dependently improved inhibitory control by decreasing the number of premature responses. Furthermore, SR141716A slightly improved attentional function, increased correct response latency, but did not affect other parameters. The CB(1) receptor agonist WIN55,212-2 did not change inhibitory control in the 5-CSRTT and only increased response latencies and errors of omissions. Coadministration of WIN55,212-2 prevented the effects of SR141716A on inhibitory control in the 5-CSRTT. Impulsive choice and response inhibition were not affected by SR141716A at any dose, whereas WIN55,212-2 slightly impaired response inhibition but did not change impulsive choice. CONCLUSIONS: The present data suggest that particularly the endocannabinoid system seems involved in some measures of impulsivity and provides further evidence for the existence of distinct forms of impulsivity that can be pharmacologically dissociated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychiatric Aspects of Impulsivity
Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M., & Swann, A. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1783 · Cited by 2,747
Evenden, J. L. (1999) · Psychopharmacology · doi:10.1007/pl00005481 · Cited by 2,044 · cited 1×
“These measures range from poor inhibitory control (impulsive action) to probability and delay aversion or impulsive choice (Barkley 1997; Evenden 1999; Moeller et al. 2001).”
BackgroundThe endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 1×
“In this respect, memory encoding, retrieval, and extinction processes have received most interest (e.g., Marsicano et al. 2002; Takahashi et al. 2005 ;V arvel et al.2005; for review, see Lichtman et al. 2002), presumably due to the high expression level of CB1 receptors in the hippocampal formation (Egertova and”
BackgroundImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · cited 1×
“High densities of CB1 receptors are also present in frontal cortical and striatal regions (Egertova and Elphick 2000; Tsou et al. 1998), suggesting involvement of the endocannabinoid system in executive functions that appear to be largely controlled by frontal corticostriatal systems (for review, see Miller and Cohen…”
BackgroundPsychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition
Sonuga-Barke, E. J. S. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00432-6 · Cited by 901
Horse-race model simulations of the stop-signal procedure
Band, G. P. H., van der Molen, M. W., & Logan, G. D. (2003) · Acta Psychologica · doi:10.1016/s0001-6918(02)00079-3 · Cited by 687
Solanto, M. V., Abikoff, H., Sonuga-Barke, E., Schachar, R., Logan, G. D., Wigal, T., Hechtman, L., Hinshaw, S., & Turkel, E. (2001) · Journal of Abnormal Child Psychology · doi:10.1023/a:1010329714819 · Cited by 639
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580 · cited 1×
“These measures range from poor inhibitory control (impulsive action) to probability and delay aversion or impulsive choice (Barkley 1997; Evenden 1999; Moeller et al. 2001).”
BackgroundChudasama, Y., Passetti, F., Rhodes, S. E. V., Lopian, D., Desai, A., & Robbins, T. W. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.020 · Cited by 518
Acute administration of d-amphetamine decreases impulsivity in healthy volunteers
de Wit, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00343-3 · Cited by 436
Winstanley, C. A., Dalley, J. W., Theobald, D. E., & Robbins, T. W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300434 · Cited by 371 · cited 1×
“In this regard, the present data add to existing clinical and preclinical evidence demonstrating that distinct measures of impulsivity can be dissociated at a pharmacological and neuroanatomical level (e.g., Chudasama et al. 2003; De Wit et al. 2002; McDonald et al. 2003; Winstanley et al. 2004).”
ResultCannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats
Cheer, J. F., Wassum, K. M., Heien, M. L. A. V., Phillips, P. E. M., & Wightman, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-04.2004 · Cited by 343
McGaughy, J., Dalley, J. W., Morrison, C. H., Everitt, B. J., & Robbins, T. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01905.2002 · Cited by 311
Eagle, D. M., & Robbins, T. W. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.6.1302 · Cited by 252
The endogenous cannabinoid system and its role in nociceptive behavior
Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203 · cited 1×
“Despite its relative recent discovery, the central endocannabinoid system has been implicated in a variety of behaviors such as food intake (for review, see Di Marzo and Matias 2005) and nociception (for review, see Cravatt and Lichtman 2004 ), and in mediating the reinforcing properties of drugs of abuse (for review,…”
BackgroundCannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat
Arguello, P. A., & Jentsch, J. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1953-0 · Cited by 49
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
The neuropharmacology of impulsive behaviour
PATTIJ, T., & VANDERSCHUREN, L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.002 · Cited by 473
Self-citationThe neurobiology of impulsivity and substance use disorders: implications for treatment
Kozak, K., Lucatch, A. M., Lowe, D. J. E., Balodis, I. M., MacKillop, J., & George, T. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13977 · Cited by 281
Leffa, D. T., Ferreira, S. G., Machado, N. J., Souza, C. M., Rosa, F. D., de Carvalho, C., Kincheski, G. C., Takahashi, R. N., Porciúncula, L. O., Souza, D. O., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14348 · Cited by 39
Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood
Hernandez, C. M., Orsini, C. A., Blaes, S. L., Bizon, J. L., Febo, M., Bruijnzeel, A. W., & Setlow, B. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120965931 · Cited by 25
Metadata
- Authors
- Pattij, T., Janssen, M. C. W., Schepers, I., González-Cuevas, G., de Vries, T. J., & Schoffelmeer, A. N. M.
- Venue
- Psychopharmacology
- Published
- 2007-03-27
- Volume
- 193
- Issue
- 1
- Pages
- 85-96
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2077269794
- Cited by
- 98
- References
- 16
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.